PropertyValue
?:abstract
  • According to this study: The antiviral remdesivir is superior to placebo in the treatment of patients hospitalized with COVID-19.A variety of therapeutic approaches are needed to continue to improve outcomes in COVID-19 patients.
?:creator
?:doi
?:doi
  • 10.1097/01.naj.0000731668.01845.8c
?:journal
  • The_American_journal_of_nursing
?:license
  • unk
?:pmid
?:pmid
  • 33350698
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • Medline
?:title
  • Remdesivir in The Treatment of COVID-19.
?:type
?:year
  • 2021-01-01

Metadata

Anon_0  
expand all